Skip to main content
MTEX
NASDAQ Life Sciences

Nasdaq Issues Delisting Notice to Mannatech Over Sub-Minimum Stockholders' Equity

Analysis by Wiseek.ai
Sentiment info
Negative
Importance info
9
Price
$4.7
Mkt Cap
$9.185M
52W Low
$4.665
52W High
$12.454
Market data snapshot near publication time

summarizeSummary

Mannatech received a Nasdaq delisting notice for failing to meet minimum stockholders' equity requirements, escalating concerns about its financial viability and stock market listing.


check_boxKey Events

  • Nasdaq Delisting Notice Received

    Mannatech was notified by Nasdaq of non-compliance with Listing Rule 5550(b)(1), requiring minimum stockholders' equity of $2.5 million.

  • Significant Equity Deficiency

    As of December 31, 2025, the company reported a stockholders' equity deficit of ($5,223,000), falling approximately $7.7 million below the Nasdaq requirement.

  • Compliance Plan Required

    The company has 45 days (until June 4, 2026) to submit a plan to regain compliance, with a potential extension of up to 180 days.

  • Listing at Risk

    Failure to regain compliance could lead to delisting from the Nasdaq Capital Market, although the notice does not result in immediate delisting.


auto_awesomeAnalysis

This 8-K reports a critical development for Mannatech, as Nasdaq has issued a formal notice of non-compliance due to the company's failure to meet the minimum stockholders' equity requirement of $2.5 million. The company's reported deficit of $5.223 million as of December 31, 2025, directly triggered this notice. While the underlying financial distress was disclosed in the recent 10-K, this formal notice escalates the risk, threatening the company's listing on the Nasdaq Capital Market. The company has 45 days to submit a compliance plan, but there is no guarantee of acceptance or successful remediation. This event, coupled with the prior going concern warning and negative financial results, significantly increases the investment risk and could further pressure the stock, which is already trading near its 52-week low.

At the time of this filing, MTEX was trading at $4.70 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $9.2M. The 52-week trading range was $4.67 to $12.45. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed MTEX - Latest Insights

MTEX
Apr 24, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
9
MTEX
Apr 24, 2026, 11:55 AM EDT
Filing Type: SCHEDULE 13D
Importance Score:
8
MTEX
Apr 21, 2026, 1:29 PM EDT
Filing Type: DEF 14A
Importance Score:
9
MTEX
Apr 15, 2026, 5:15 PM EDT
Source: Wiseek News
Importance Score:
9
MTEX
Apr 15, 2026, 5:14 PM EDT
Filing Type: 8-K
Importance Score:
9
MTEX
Apr 15, 2026, 5:08 PM EDT
Filing Type: 10-K
Importance Score:
10
MTEX
Apr 01, 2026, 6:47 PM EDT
Filing Type: 8-K
Importance Score:
9
MTEX
Apr 01, 2026, 6:47 PM EDT
Source: GlobeNewswire
Importance Score:
8
MTEX
Mar 24, 2026, 11:36 AM EDT
Filing Type: 8-K
Importance Score:
7